ﺮ ﺎ ﺻ ﻌﻣ ﻪﻫﺍ ﺒ ﺪ ﺍﻟ ﻓ

Similar documents
Preparation of TAMIFLU for Oral Suspension. Emergency Compounding of an Oral Suspension from TAMIFLU Capsules (Final Concentration 15 mg/ml)

This letter is to notify you of recent changes to the TAMIFLU product monograph. Please note, additions/changes have been highlighted in yellow.

Lab. No. 1 Second Semester Suspensions

Formulation Guidelines for Synovea HR

COMPOUNDING WITH PHLOJEL Ultra (PU) Slab & Spatula or mortar & pestle

Emulsions. Purpose of emulsions and of emulsification:

Formulation Guidelines for Synovea HR

Dermatological preparations for the tropics

Practical 3 Extemporaneous Preparations Solutions. Name: Group: Date:

TEGOSOFT DEC Emollient for formulations with a light skin feel

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

THERMALLY OXIDIZED SOYA BEAN OIL

Student Practical Guide (1) Milk of Magnesia

Selecting the Primary Emollient to Enhance the Vitamin E- Acetate Skin Penetration

Mixed solvent systems;; spirits, and elixirs

MIGLYOL Gel B, Gel T, 840 Gel B

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

6.02 Uniformity of Dosage Units

Stability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date

Introduction to Compounding INTRODUCTION. L earning Objectives CHAPTER

Emollient for formulations with a light skin feel

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Example Problem 1 In what proportion should alcohols of 95% and 50% be mixed to make 70% alcohol? Proportion (or ratio) = 4 parts of A : 5 parts of B

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

Change to read: BRIEFING

Determination of sodium benzoate in fruit juice. BCH445 [Practical] 1

4. Determination of fat content (AOAC, 2000) Reagents

Concentrations and Dilutions INTRODUCTION. L earning Objectives CHAPTER

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

SOFTISAN 100, 142, 154

Purity Tests for Modified Starches

PRODUCT MONOGRAPH. Pr TAMIFLU. oseltamivir capsule 30 mg, 45 mg and 75 mg oseltamivir (as oseltamivir phosphate)

TEGO Carbomer 341 ER Emulsion stabilizer, viscosity enhancer for aqueous solutions with high electrolyte tolerance

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry:

Pharmaceutical Preparation For Internal Use

TECHNICAL BULLETIN METHOD 1: DETERMINATION OF TOTAL DIETARY FIBRE

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

PATIENT INFORMATION What is VITRAKVI? and and

Finsolv EB. Ethylhexyl Benzoate. INCI Name: Ethylhexyl Benzoate CAS No.: EINECS No.:

LAB.2. Tablet Production Methods

Stability Of Extemporaneously Prepared Oral Liquid Formulations Part XI

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

TEGOSOFT APM Very high polar cosmetic oil with excellent thickening properties for surfactant formulas

Reagent Set DAS ELISA, Alkaline phosphatase label

Indotec Chemicals & Polymers

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

CELLULASE from PENICILLIUM FUNICULOSUM

PVY Reagent Set Compound ELISA, Alkaline phosphatase label Potato virus Y Catalog number: SRA 20001

Hosta virus X ELISA KIT

Parenteral products-definition

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

ABIL Care 85 Emulsifier for O/W emulsions with a velvety-silky skin feel

PERCENTAGE and RATIO STRENGTH

E55A GELATIN, GELLING GRADE Gelatina

Secundum Artem. STABILITY OF EXTEMPORANEOUSLY PREPARED ORAL LIQUID FORMULATIONS Part V

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Potato leafroll virus (PLRV) Reagent Set DAS ELISA, Alkaline phosphatase label Catalog number: SRA List of contents

Granulation Aggregation

Emulsion stabilizer, viscosity enhancer for aqueous solutions with high electrolyte tolerance

Blueberry scorch virus Reagent Set DAS ELISA, Alkaline phosphatase label for BlScV Catalog number: SRA 19100

Esters with Improved Hydroalcoholic Solubility. Posted February 15, 2008

Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

Reagent Set DAS ELISA, Alkaline phosphatase label SRA 22001, SRA 23203, SRA 27703, SRA & SRA ToRSV, ArMV, GFLV, AnFBV and PDV

Addendum to the 2016 FAO/WHO Manual on pesticide specifications: revised Tablet Specifications for DT, ST and WT

New Tradename: TEGO Cosmo C 250

Secundum Artem. Stability of Extemporaneously Prepared Oral Liquid Formulations - Part VII

Formulation Guidelines for Synastol TC

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier

Acids. Chemical GS HT UT UR XP HD

Arbonne Essentials Calcium Plus

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

Hydrocortisone 2%, Hydroquinone 6%, Kojic Acid 4%, Salicylic Acid 4%, Tretinoin 0.01% Topical Gel (Suspension, 20 g)

Product Information:

TYPES OF DISPENSED PREPARATIONS

22. The Fischer Esterification

BRIEFING Assay + + +

Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy

Appendix II. Barton's reagent:

Pediatric patients needing an oral solution sensitivity to dyes Dermatological formulations

PRODUCT LIST GENERAL - TABLETS

Pharmaceutical Calculations

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

(12) United States Patent (10) Patent No.: US 6,440,428 B1

PRODUCT LIST. Human Nutrition

Experiment 2: Melting Points and the Identification of an Unknown and Cholesterol from Human Gallstones

Food & Beverage Brochure

Personal Care. Cremophor A Grades. Technical Information

Secundum Artem. Stability of Extemporaneously Prepared Oral Liquid Formulations - Part VII

IN-VITRO RELEASE STUDY OF IBUPROFEN FROM DIFFERENT TOPICAL FORMULATIONS

Derived from fully hydrogenated castor oil, specifically developed and manufactured for cosmetics.

DIHYDROXYACETONE. Extratan TM INTRODUCTION STABILITY. M.C. Biotec Inc. Page 1 of 5. A safer alternative to sunbathing

Cereal yellow dwarf virus - RPV ELISA Kit

Transcription:

Compounding Resources s Dr Abbas Pardakhty 2011 Kerman Faculty of Pharmacy ١ ٢ Compounding - Contemporaryمعاصر - Extemporaneousفي البداهه ٣ ٤ ٥ ٦ ١

M ethod of Preparation: Calculate the quantity of each ingredient for the amount to be prepared. Accurately weigh or measure each i ngredient. Combine the glyceryl stearate, cetyl a lcohol, petrolatum, and mineral oil, and heat t he mixture to about 6 0 C to 7 0 C. Dissolve the u rea in about 4 0 m L of purified wate r. Mix the t erbinafine, Carbopol 9 4 0, and xanthan gum w ith the propylene glyco l. Incorporate the propylene glycol solution into the urea solution ; m ix well and heat to about 6 0 C to 7 0 C. C ombine the two mixtures and mix whil e agitating to form an emulsion. Add th e trolamine; while the mixture is cooling, add sufficient purified water to final weight and mix well. Package and label. ٧ ٨ U se: This preparation has been used in the treatment of fungal infections. Packaging: Package in tight, light- resistant containers. L abeling: For external use only. Keep out of the reach of children. Discard after [time period]. Stability: A beyond- u se date of up to 30 d ays may be used for this preparation. 1 Quality Control: Quality- control assessment can include theoretical weight compared with actual weight, specific gravity (SG), active drug assay, color, texture-surface, texture- spatula spread, appearance, feel, rheologic properties, and physical observations. http://dir.pharmacy.dal.ca/compoun.php ٩ ١٠ http://www.paddocklabs.com/secundum_artem.html ١١ ١٢ ٢

١٣ ١٤ ١٥ ١٦ ١٧ ١٨ ٣

١٩ ٢٠ ٢١ ٢٢ http://www.cheo.on.ca/en/healthcareprofessionalsforpharmacist ttp://www.cheo.on.ca/en/healthcareprofessionalsforpharmacists s ٢٣ ٢٤ ۴

٢٥ ٢٦ http://www.olhsc.ie/departments/pharmacy/extemporaneouscompounding/ ٢٧ ٢٨ R x P soriasis Lotion ( 100 m L) C oal tar solution 5 S alicylic acid 5 g U rea 10 g Triamcinolone a cetonide 160 mg P ropylene glycol qs 100 www.fda.org D issolve the urea and salicylic acid in about 75 m L of p ropylene glycol; this may take 30 t o 45 minutes. Add the triamcinolone a cetonide a nd mix well. Incorporate the coal t ar solution and mix w ell. Add sufficient propylene glycol to m ake 100 m L and thoroughly mix. Package and label. C oal tar Solution: coal tar 20%, p olysorbate 80 5 %, in alcohol ( 96%), ٢٩ ٣٠ ۵

Ingredients Purified water, glycerin, sorbitol, sodium saccharin, xanthan gum, and flavoring. Buffered with citric acid and sodium citrate. Preserved with methylparaben ( 0. 03%), propylparaben ( 0. 008%), and potassium sorbate ( 0.1 %). ٣١ ٣٢ B ody Weight (kg) Body Weight (lbs) 16 < 15 kg < 33 lbs t o 23 k g 34 t o 51 l bs Total Volume to Compound per patient () 30 40 Total Volume of Compounded Oral Suspension needed to be Prepared 30 m L 40 m L 50 m L 60 Required number of 6 c apsules ( 450 8 c apsules ( 600 10 c apsules ( 750 12 c apsules ( 900 T AMIFLU 75 mg Capsules mg oseltamivir) mg oseltamivir) mg oseltamivir) mg oseltamivir) Required volume of vehicle 24 t o 40 k g 52 t o 88 l bs > 41 kg > 89 lbs 50 60 Cherry Syrup (Humco) OR Ora-Sweet SF (Paddock Laboratories) 29 38. 5 m L 48 m L 57 ٣٣ ٣٤ Carefully separate the capsule body and cap and transfer the contents of the required number of T AMIFLU 75 mg Capsules into a clean mortar. Triturate the granules to a fine powder. Add one- third ( 1/3 ) of the specified amount of vehicle and triturate the powder until a uniform suspension is achieved. Transfer the suspension to an amber glass or amber p olyethyleneterephthalat e ( PET) bottle. A funnel may be used to eliminate any spillage. Add another one- third ( 1/3 ) of the vehicle to the mortar, rinse the pestle and mortar by a triturating motion and transfer the vehicle into the bottle. Repeat the rinsing (Step 5 ) with the remainder of ٣٥ the vehicle. Shake well to completely dissolve the active drug and to ensure homogeneous distribution of the dissolved d rug in the resulting suspension. (Note: The active drug, o seltamivir p hosphate, readily dissolves in the specified vehicles. The suspension is caused by some of the inert ingredients of TAMIFLU Capsules which are insoluble in these vehicles.) Put an ancillary label on the bottle indicating "Shake Gently Before Use". [This compounded suspension should be gently shaken prior to administration to minimize the tendency for air entrapment, particularly with the Ora- Sweet SF preparation.] Instruct the parent or guardian that any remaining material following completion of therapy must be discarded by either affixing an ancillary label to the bottle or adding a statement to the pharmacy label ٣٦ instructions. Place an appropriate expiration date label according to ۶

STORAGE OF THE PHARMACY- COMPOUNDED SUSPENSION: R efrigeration: S table for 5 w eeks ( 35 days) when stored in a refrigerator at 2 to 8 C ( 36 to 46 F). R oom Temperature: S table for five days ( 5 days) when stored at room temperature, 25 C ( 77 F). Solubility of the pharmaceuticals ٣٧ ٣٨ Official solubility v ery soluble: 1 i n less than 1 f reely soluble: 1 i n 1 t o 1 i n 10 s oluble: 1 i n 10 t o 1 i n 30 s paringly soluble: 1 i n 30 t o 1 i n 100 s lightly soluble: 1 i n 100 t o 1 i n 1000 v ery slightly soluble: 1 i n 1000 t o 1 in 10 000 p ractically insoluble: 1 in more than 10 000 ٣٩ ٤٠ S olubility of Glycolic acid: Easily soluble in cold water. Soluble in methanol, diethyl ether, acetone. Solubility: Partially soluble in cold water. S olubility in water: 1 g /l at 1 C; 2. 4 g /l at 20 C.; 8. 2 g/l a t 50 C ; 22 g /l at 65 C. Alcohol: Freely Soluble Ether: Very Soluble Freely soluble in boiling water Warning - Pregnant women or those who may become pregnant should not be exposed to this chemical ٤١ ٤٢ ٧

Clindamycin phosphate 1 in 2. 5 water S olubility: Soluble in cold water, hot water, methanol, ethanol, glycerin and diethyl ether. ٤٣ ٤٤ Kojic acid Soluble in water and alcohol. Alcohol and PG ٤٥ ٤٦ Alcohol & PG 1 i n 3 alcohol 1 i n 15 boiling water 1 i n 10 castor oil ٤٧ ٤٨ ٨

Sulfurated potash PABA A mixture of potassium polysulfides, sulfite and thiosulfite. 1 i n 2 water Freely soluble in ethanol. ٤٩ ٥٠ Urea ٥١ 1 in 1. 5 water 1 i n 10 alcohol E rythromycin base: 1 m g per 1 ml of water. e stolate (erythromycin propionate l auryl sulfate): practically insoluble in water. e thylsuccinate: slightly soluble in water. l actobionate: freely soluble in water. g luceptate: freely soluble in water. ٥٢ Dioxybenzone, 8-Benzophenone E rythromycin base: soluble in alcohol. e stolate (erythromycin propionate l auryl sulfate): soluble in alcohol ( 50 m g per 1 ml alcohol). e thylsuccinate: freely soluble in alcohol. l actobionate: freely soluble in alcohol. g luceptate: freely soluble in alcohol. ٥٣ ٥٤ Alcohol Toluene ٩

Dithranol, Anthralin Resorcinol Fixed oils Acetone Chloroform 1 i n less than 1 i n 1 water 1 alcohol ٥٥ ٥٦ Formulations Azelaic acid cream 20% Azelaic acid 20g elt and S tearic mix lipid acid phase at 9g D issolve aq. Phase at 75 C C etyl alcohol 10 g W hite soft paraffin 4g Propylene glycol 8g Triethanolamine 2g Methyl parabene 0. 18g Propyl parabene 0. 02g Purified water to 100g M 70 C ٥٧ ٥٨ Azelaic acid cream Aminobenzoin acid lotion Azelaic acid 10-20g Purified water 40ml Eucerin to 100g Dissolve Azelaic acid in 85 C water. Add and mix gradually with Eucerin PABA 5g Glycerol 20ml A lcohol 60 ml Freshly boiled and cooled water to 100ml Dissolve PABA in alcohol, add glycerin then water. ٥٩ ٦٠ ١٠

٦١ and Zinc acetate lotion Zinc acetate 1.2g PG 10ml Alcohol 70% to 100ml Dissolve in 67.5 ml Alcohol 96 and add PG. Dissolve Zinc acetate in water and mix. 4g ٦٢ Aluminium acetate solution (Burow s solution) Aluminium sulfate 22.5g Acetc acid ( 33% ) 25ml Calcium carbonate 10g Water 75ml Tartaric acid 4.5g 6 ml warm water and cool to RT. Dissolve Al2( SO4) 3 in 0 Add acetic acid. Disperse calcium carbonate in water to form a suspension. Mix two phases and store in a cool place for 24 h. Filter it and add tataric acid and store at cool place. Acetic acid ear drop Acetic acid ( 33% ) 3ml Freshly boiled and cooled water to 100ml Compound benzoic acid ointment Whitefield s ointment Benzoic acid Salicylic acid (B.P.), Emulsifying ointment to 100g 6g 3g Levigate the powders in liquid paraffin and add geometrically to emuls. oint. ٦٣ ٦٤ Shohl s solution Kojic acid cream Citric acid monohydrate 14g Sodium citrate 9.8g Water to 100ml Used for Nephritic tubular acidosis. Citric acid 12.8g Sodium citrate 9.8g Water to 100ml Kojic acid 3g Purified water 20ml Dissolve kojic acid in water. Add and mix gradually with Eucerin. Eucerin to 100g ٦٥ ٦٦ ١١